That said, the series of patient-derived variants associated with schizophrenia, bipolar disorder, and epilepsy within the β3-β4 loop of GEF2 suggests its potential in regulating either inter- or intramolecular interactions crucial for TRIO signaling. This evidence concerns the gene GABARAPL2 and schizophrenia.